crazyjogger925 wrote: friday march 19,2020 press release

New Post Public Reply Private Reply Replies (1) Message Board
blafarm crazyjogger925 #22620
539
crazyjogger925 wrote:

Quote:
friday march 19,2020 press release please note words" sickest covid-19 patients"


Press Release:
Quote:
A leading academic medical center has administered the test medication, leronlimab, in two of their sickest COVID-19 patients.

crazyjogger925, not sure WHO you were responding to, or WHAT you were responding to -- but just wanted to shed a little light on the actual condition of those two patients as described by NP in the last call.

The Press Release quote includes the all-important qualifier: "their" -- which only means those are the sickest patients that they have -- but not the sickest patients that can be found with COVID-19.

NP stated that those two patients were NOT in later stage ARDS. Please see the excerpt below in which I have bolded meaningful text, added missing characters or words in [brackets] , and colored in red meaningLESS text.

And, of course, here is a link to the recording: https://www.youtube.com/watch?v=SPqa6F0rVXE

38:09 [Question] okay so Tony's asking how are the two
38:11 virus patients have the two virus
38:14 patients been diagnosed with a [A]RDS prior
38:18 to the injection or [h]as the disease
38:19 disease not progress[ed] that for you
38:24 [Answer]yes so these patients are severe lung
38:28 disease but it's not [AR]DSS and I
38:32 think you know again what we're trying
38:35 to do is break up this vicious cycle of
38:40 means of coming in producing cytokines
38:43 which bring in more immune cells which
38:45 produce more other kinds and break that
38:48 vicious cycle before they get here
38:51 reversible lung damage and so we're very
38:55 hopeful

It is likely that you already knew this, just thought it was worth making this distinction.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Nokia Corporation's Recent Management Transaction Highlights

Updated Category News Views 135

Nokia Corporation's Latest Management Transactions Nokia Corporation has recently announced significant management transactions that emphasize its ongoing operational strategies and technological innovations. Today, we dive into the details of one particular transaction involving a key manager in the company. Transaction Details This transaction notification is made under...

Continue Reading
Huawei's Innovative AI WAN Solution Revolutionizes Networking

Updated Category News Views 262

Huawei's New AI WAN Solution Unveiled At the Mobile World Congress in Barcelona, Huawei introduced the AI WAN Solution, a groundbreaking development designed to revolutionize networking. Leon Wang, the President of Huawei's Data Communication Product Line, emphasized the importance of merging AI with network infrastructures. This new solution aims to enhance IP networks...

Continue Reading
Transforming Business Dreams with Innovative Software Solutions

Updated Category News Views 114

Transforming Business Dreams with Innovative Software Solutions FM, a pioneer in custom software development augmented by AI technology, is revolutionizing how businesses approach growth and scalability. In a rapidly changing landscape, where adaptability is key, FM’s approach enables organizations to leverage generative software solutions that are more accessible than...

Continue Reading
Investment in Caesars Palace Times Square Promises Growth

Updated Category News Views 171

Community Investment and Support for Caesars Palace Times Square During a recent public hearing, community support was overwhelmingly evident for the Caesars Palace Times Square project. Local residents, small business owners, union workers, and city leaders gathered to express their enthusiasm for a project that promises to generate significant economic growth and create...

Continue Reading
Aquestive Therapeutics Reaches Milestone with FDA Notification

Updated Category News Views 114

Groundbreaking News from Aquestive Therapeutics Aquestive Therapeutics, Inc. (NASDAQ: AQST), a forward-thinking pharmaceutical company dedicated to enhancing patient care through innovative drug delivery solutions, has officially received word from the U.S. Food and Drug Administration (FDA) that no advisory committee meeting will be required for the New Drug Application...

Continue Reading